BioAdvance News

QR Pharma Awarded SBIR Grant by NIA/NIH to Test Posiphen® and Metabolites in Various Models

By WebmasterSeptember 21, 2010November 1st, 2024No Comments

QR Pharma Awarded SBIR Grant by NIA/NIH to Test Posiphen® and Metabolites in Various Models
Read more here

Previous PostYaupon Announces Results from Pivotal Study
Next PostPhoenix S&T Announces Expanded Availability of Capillary LC Column Heaters and Controllers in US and EU